Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Laryngeal Mask Airway (LMA) Protector for Minimally Invasive Thyroidectomy

12 de noviembre de 2017 actualizado por: Georgios Kotsovolis, 424 General Military Hospital

Study of the Laryngopharyngeal Symptoms After Minimally Invasive Thyroidectomy: Comparison Between the Protector Laryngeal Mask Airway and the Endotracheal Tube.

The patients will be allocated to 2 groups: the LMA group and the endotracheal tube (ET) group. Airway management will be done with the LMA Protector for the patients of the LMA group and with the classic endotracheal tube for the patients of the ET group. The main purpose of the study is to determine if the application of the LMA Protector causes less laryngopharyngeal symptoms than the endotracheal tube after minimally invasive thyroidectomy. The secondary purpose is to confirm that the LMA Protector is a safe alternative airway management device for minimally invasive thyroidectomy.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

79

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Thessaloniki, Grecia, 54636
        • Ahepa University Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Total thyroidectomy with the minimally invasive method.
  • American Society of Anesthesiologists (ASA) classification 1-3

Exclusion Criteria:

  • Clinical conditions which cause any kind of airway obstruction or compromise.
  • Tracheal displacement greater than 2cm from midline.
  • History of gastroesophageal reflux disease.
  • Expected difficult airway.
  • History of impossible intubation.
  • BMI>35
  • Reoperation within 24hours.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: LMA Protector
After induction of general anesthesia, the LMA Protector will be applied for airway management. The size of the laryngeal mask will be chosen according to the manufacturer's instructions. Lubricant gel will be applied to the dorsal side of the mask to ease the insertion to the oropharynx. The cuff of the mask will be filled with air by syringe until the indication of the integrated cuff pressure indicator is appropriate according to the manufacturer (green indication). If the indication changes during surgery, air will be added or removed accordingly. If the ventilation of the patient is inadequate at the beginning or anytime during the operation, the mask will be removed and the patient will be intubated
After induction of general anesthesia, the LMA Protector will be applied for airway management. The size of the laryngeal mask will be chosen according to the manufacturer's instructions. Lubricant gel will be applied to the dorsal side of the mask to ease the insertion to the oropharynx. The cuff of the mask will be filled with air by syringe until the indication of the integrated cuff pressure indicator is appropriate according to the manufacturer (green indication). If the indication changes during surgery, air will be added or removed accordingly. If the ventilation of the patient is inadequate at the beginning or anytime during the operation, the mask will be removed and the patient will be intubated.
Comparador activo: Endotracheal tube
After induction of general anesthesia, the endotracheal tube be applied for airway management. The size of the tube will be 7.5 for female and 8.5 for male patients. The cuff of of the tube will be filled with 10ml air.
After induction of general anesthesia, the endotracheal tube be applied for airway management. The size of the tube will be 7.5 for female and 8.5 for male patients. The cuff of of the tube will be filled with 10ml air.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Postoperative sore throat.
Periodo de tiempo: Within 20 minutes from the end of the procedure.
The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
Within 20 minutes from the end of the procedure.
Postoperative sore throat.
Periodo de tiempo: 1 hour after the exit from the recovery room.
The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
1 hour after the exit from the recovery room.
Postoperative sore throat.
Periodo de tiempo: 6 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
6 hours after the exit from the recovery room.
Postoperative sore throat.
Periodo de tiempo: 12 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
12 hours after the exit from the recovery room.
Postoperative sore throat.
Periodo de tiempo: 24 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative constant pharyngeal pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
24 hours after the exit from the recovery room.
Postoperative surgical site pain.
Periodo de tiempo: Within 20 minutes from the end of the procedure.
The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
Within 20 minutes from the end of the procedure.
Postoperative surgical site pain.
Periodo de tiempo: 1 hour after the exit from the recovery room.
The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
1 hour after the exit from the recovery room.
Postoperative surgical site pain.
Periodo de tiempo: 6 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
6 hours after the exit from the recovery room.
Postoperative surgical site pain.
Periodo de tiempo: 12 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
12 hours after the exit from the recovery room.
Postoperative surgical site pain.
Periodo de tiempo: 24 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative surgical trauma pain by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
24 hours after the exit from the recovery room.
Postoperative dysphagia.
Periodo de tiempo: Within 20 minutes from the end of the procedure.
The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
Within 20 minutes from the end of the procedure.
Postoperative dysphagia.
Periodo de tiempo: 1 hour after the exit from the recovery room.
The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
1 hour after the exit from the recovery room.
Postoperative dysphagia.
Periodo de tiempo: 6 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
6 hours after the exit from the recovery room.
Postoperative dysphagia.
Periodo de tiempo: 12 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
12 hours after the exit from the recovery room.
Postoperative dysphagia.
Periodo de tiempo: 24 hours after the exit from the recovery room.
The patients will be asked to evaluate their postoperative pharyngeal pain caused after swallowing one sip of water by using the 11grade Numerical Rating Scale (0 no pain, 10 maximum possible pain).
24 hours after the exit from the recovery room.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Airway management difficulty.
Periodo de tiempo: 3 minutes after induction of general anesthesia.
The efforts required to establish a secure airway and manage adequate patient ventilation will be recorded.
3 minutes after induction of general anesthesia.
Airway management complications.
Periodo de tiempo: Within 5 minutes from induction of general anesthesia.
Any complication from airway management will be recorded like bleeding from the stomatopharynx or the larynx, tooth trauma, lip trauma, etc.
Within 5 minutes from induction of general anesthesia.
Emergence coughing.
Periodo de tiempo: Within 10 minutes from the end of the surgery.
The incidence of cough upon emergence from general anesthesia will be recorded.
Within 10 minutes from the end of the surgery.
Postoperative paracetamol consumption.
Periodo de tiempo: 1, 6, 12 and 24 hours after emergence from general anesthesia.
The patients will be instructed to ask for analgesics as needed. When rescue analgesia is required 1000mg paracetamol will be administered. The frequency of paracetamol administration will be documented.
1, 6, 12 and 24 hours after emergence from general anesthesia.
Postoperative hoarseness.
Periodo de tiempo: Within 20 minutes from the end of the procedure and after 1, 6, 12 and 24 hours.
The patients postoperative hoarseness will be evaluated according to the GRBAS scale.
Within 20 minutes from the end of the procedure and after 1, 6, 12 and 24 hours.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de febrero de 2017

Finalización primaria (Actual)

30 de octubre de 2017

Finalización del estudio (Actual)

1 de noviembre de 2017

Fechas de registro del estudio

Enviado por primera vez

22 de marzo de 2017

Primero enviado que cumplió con los criterios de control de calidad

28 de marzo de 2017

Publicado por primera vez (Actual)

4 de abril de 2017

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

14 de noviembre de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2017

Última verificación

1 de noviembre de 2017

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre LMA Protector

3
Suscribir